Both in Pharmaceuticals
Akebia Therapeutics vs CAMP4 Therapeutics
Over the past year AKBA returned −67.3% and CAMP returned +27.4%; their daily moves had a correlation of 0.15.
AKBA −67.3% CAMP +27.4%Growth of $1, one year, split-adjusted
| Metric | AKBA | CAMP |
|---|---|---|
| Price | $0.8861 | $3.91 |
| Market cap | $245.5M | $245.4M |
| Today | −0.78% | +1.56% |
| 1 month | +0.9% | −5.8% |
| 6 months | −32.9% | −2.3% |
| Year to date | −45.0% | −36.2% |
| 1 year | −67.7% | +31.2% |
| Revenue growth (YoY) | −21.4% | +18.8% |
| Gross margin | 78.8% | 100.0% |
| Net margin | −18.1% | −1884.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | 58.2× |
| Net cash | $106.0M | $86.4M |
| Dividend yield | — | — |
| Volatility (60d) | 81.8% | 97.1% |
| Short % of float | 7.7% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).